← Evidence map

ReviewDrug design, development and therapy2017

Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future.

David Ah Whiteman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

49 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28860717